SearchCatalogResearchCommunityTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Neuroprotection / Neuroplasticity StackEvidence Grade: C (Dihexa) / B (Cerebrolysin)

Dihexa + Cerebrolysin Stack Protocol Guide

The Dihexa + Cerebrolysin stack is an advanced neuroprotective combination for neuroplasticity and cognitive restoration. Dihexa is a HGF/c-Met receptor agonist reported to be millions of times more potent than BDNF at promoting synaptogenesis in animal models. Cerebrolysin is a porcine brain-derived peptide preparation containing neurotrophic factors used clinically for decades in Europe/Asia for stroke recovery, TBI, and cognitive decline. Together, Dihexa drives new synapse formation while Cerebrolysin provides neurotrophic support for neuronal survival and repair. This is an advanced/experimental stack due to limited human data on Dihexa.

Protocol Overview

Compounds
Dihexa + Cerebrolysin
Category
Neuroprotection / Neuroplasticity
Mechanism
Dihexa: HGF/c-Met agonism, synaptogenesis. Cerebrolysin: neurotrophic factor blend, neuronal survival, synaptic plasticity
Half-Life
Dihexa: ~12 hrs (oral) | Cerebrolysin: variable
Route
Dihexa: Oral or SubQ | Cerebrolysin: IM or IV
Frequency
Dihexa: 1x daily | Cerebrolysin: 5x/week
Cycle Length
4-8 weeks (with breaks)

Synergy & Mechanism

Dihexa Mechanism

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) activates the HGF/c-Met receptor pathway, one of the most powerful drivers of synaptogenesis and dendritic spine formation. In animal models it restored cognitive function in aged rats and models of neurodegeneration. It promotes the formation of new synaptic connections at potencies far exceeding BDNF.

Cerebrolysin Synergy

Cerebrolysin provides a balanced cocktail of neurotrophic factors, neuropeptides, and gangliosides that support neuronal survival, reduce apoptosis, and enhance synaptic plasticity. While Dihexa creates new synaptic connections, Cerebrolysin nourishes and protects both new and existing neurons. Clinical data supports its use in stroke recovery and Alzheimer disease.

Combined Dosing Protocol

ProtocolCompound 1Compound 2TimingDuration
ConservativeDihexa 10mg oral dailyCerebrolysin 5mL IM 5x/weekAM oral, AM IM4 weeks
StandardDihexa 20mg oral dailyCerebrolysin 5mL IM 5x/weekAM4-8 weeks
ResearchDihexa 5mg SubQ dailyCerebrolysin 10mL IM 5x/weekAM4 weeks on, 2 off

Reconstitution & Preparation

Dihexa Preparation

  • Dihexa capsules: typically 10mg or 20mg
  • Also available as sublingual solution
  • Oral bioavailability is reasonable
  • Store at room temperature, away from light

Cerebrolysin Preparation

  • Pre-filled ampules: 1mL, 5mL, 10mL
  • Ready to use, no reconstitution
  • Administer IM (deltoid or glute) or slow IV
  • Store refrigerated 2-8°C

Stacking Schedule (AM/PM Timing)

AM Protocol

  • Morning: Dihexa 10-20mg oral on empty stomach
  • Morning: Cerebrolysin 5mL IM injection
  • Weekdays only for cerebrolysin (Mon-Fri)
  • Dihexa daily including weekends

PM Protocol

  • No PM dosing required
  • Engage in cognitive tasks to leverage neuroplasticity
  • Quality sleep critical for memory consolidation
  • Avoid alcohol during protocol

Expected Timeline

Day 1-7
Cerebrolysin neurotrophic effects begin. Dihexa starts HGF/c-Met signaling. Subtle improvements in clarity and recall.
Week 2-3
Synaptogenesis from dihexa becoming active. Noticeable improvements in memory, learning speed, cognitive stamina.
Week 4-6
Peak neuroplasticity. Significant cognitive improvements. New synaptic connections consolidating. Best period for intense learning.
Week 6-8
Sustained benefits. Cycle off dihexa after 8 weeks (2-4 week break). Cerebrolysin effects persist 2-3 months.

Side Effects & Monitoring

Common Side Effects

  • Headache (cerebrolysin, first few days)
  • Dizziness (uncommon)
  • Injection site pain (cerebrolysin IM)
  • Insomnia if dihexa taken late
  • Vivid dreams

Precautions

  • Dihexa has very limited human safety data
  • HGF/c-Met pathway may promote certain cancers
  • Cerebrolysin: pork-derived - avoid if allergic
  • Epilepsy: cerebrolysin may lower seizure threshold (rare)
  • Short cycles with breaks recommended

Blood Work Recommendations

PanelMarkersTiming
BasicCBC, CMPBaseline, Week 4
LiverALT, AST, GGTBaseline, Week 4
InflammatoryCRPBaseline, Week 4

Liver monitoring important given experimental nature of dihexa. Consider formal cognitive testing to objectively measure improvements.

Related Protocols & Tools

★ OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership ยท Learn more
Share & Save
๐• Share on Twitter ๐Ÿ“ฑ Share on Reddit ๐Ÿ’ฌ WhatsApp โœ‰๏ธ Email ๐Ÿ”— Copy Link ๐Ÿ–จ๏ธ Print / Save PDF โ˜… Save to Favorites